{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:08:04Z","timestamp":1785485284454,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cardfail.2022.10.432","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T01:24:11Z","timestamp":1670721851000},"page":"258-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Angiotensin Receptor Neprilysin Inhibitor Use and Blood Pressure Lowering in Patients With Heart Failure With Reduced Ejection Fraction Across the Spectrum of Kidney Function: An Analysis of the Veterans Administrative Health System"],"prefix":"10.1016","volume":"29","author":[{"given":"GRENITA","family":"GJYRIQI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIKAELA","family":"YORK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FARAH","family":"ABUAZZAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHARLES A.","family":"HERZOG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SRIPAL","family":"BANGALORE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEVIN BRYAN","family":"LO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MANDEEP S.","family":"SIDHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MUTHIAH","family":"VADUGANATHAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JANANI","family":"RANGASWAMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-3165","authenticated-orcid":false,"given":"ROY O.","family":"MATHEW","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2022.10.432_bib0001","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/eurheartj\/ehab499","article-title":"Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction","volume":"42","author":"Jackson","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/HYPERTENSIONAHA.116.08556","article-title":"Effects of Sacubitril\/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: the PARAMETER Study","volume":"69","author":"Williams","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0003","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A Randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009229","article-title":"Blood pressure and glycemic control among ambulatory US adults with heart failure: National Health and Nutrition Examination Survey 2001 to 2018","author":"Rethy","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0006","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0007","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehv142","article-title":"Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials","volume":"36","author":"Bavishi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0008","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.118.034818","article-title":"Effects of sacubitril\/valsartan versus irbesartan in patients with chronic kidney disease","volume":"138","author":"Haynes","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0009","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.HYP.0000114571.75762.b0","article-title":"Arterial stiffness and kidney function","volume":"43","author":"Safar","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0011","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2215\/CJN.14610920","article-title":"Resistant hypertension in CKD","volume":"16","author":"Thomas","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0012","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ajh.2009.240","article-title":"Aortic PWV in chronic kidney disease: a CRIC ancillary study","volume":"23","author":"Townsend","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0013","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11906-016-0694-x","article-title":"From ARB to ARNI in cardiovascular control","volume":"18","author":"Uijl","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0014","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000519014","article-title":"Patterns of use and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure and changes in kidney function: an analysis of the Veterans\u2019 Health Administrative Database","volume":"11","author":"Mathew","year":"2021","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0015","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin c-based equations to estimate GFR without ace","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0016","first-page":"1","article-title":"Multivariate Imputation by Chained Equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Statist Softw"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Statist Softw"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.32614\/RJ-2017-046","article-title":"Visualization of regression models using visage","volume":"9","author":"Breheny","year":"2017","journal-title":"R J"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0019","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0020","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.amjhyper.2003.09.014","article-title":"Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial","volume":"17","author":"Kostis","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0022","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0023","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0024","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jcph.571","article-title":"Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor","volume":"56","author":"Gan","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107891","article-title":"Sex-related differences in the pharmacological treatment of heart failure","volume":"229","author":"Tamargo","year":"2022","journal-title":"Pharmacol Therapeut"},{"issue":"3","key":"10.1016\/j.cardfail.2022.10.432_bib0026","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","article-title":"Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"30","author":"Raebel","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0027","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of hypertension in chronic kidney disease","volume":"79","author":"Pugh","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.cardfail.2022.10.432_bib0028","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916422012143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916422012143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:48:48Z","timestamp":1761029328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916422012143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1071916422012143"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.10.432","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin Receptor Neprilysin Inhibitor Use and Blood Pressure Lowering in Patients With Heart Failure With Reduced Ejection Fraction Across the Spectrum of Kidney Function: An Analysis of the Veterans Administrative Health System","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.10.432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}